NeuroPace Inc (NPCE)
13.69
-0.31
(-2.21%)
USD |
NASDAQ |
Apr 19, 16:00
13.69
0.00 (0.00%)
After-Hours: 19:51
NeuroPace Cash from Operations (TTM): -19.70M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.70M |
| September 30, 2023 | -24.20M |
| June 30, 2023 | -28.88M |
| March 31, 2023 | -35.17M |
| December 31, 2022 | -36.87M |
| September 30, 2022 | -37.23M |
| June 30, 2022 | -34.68M |
| Date | Value |
|---|---|
| March 31, 2022 | -30.03M |
| December 31, 2021 | -24.58M |
| September 30, 2021 | -22.80M |
| June 30, 2021 | -23.80M |
| March 31, 2021 | -21.00M |
| December 31, 2020 | -21.61M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-37.23M
Minimum
Sep 2022
-19.70M
Maximum
Dec 2023
-27.73M
Average
-24.58M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Ainos Inc | -4.695M |
| OpGen Inc | -16.64M |
| Zomedica Corp | -15.98M |
| LENSAR Inc | -9.659M |
| Eargo Inc (DELISTED) | -75.37M |